CDC advisers update recommendations for meningococcal, RSV, chikungunya vaccines
University of Minnesota http://twin-cities.umn.edu/ 612-625-5000 Following a 2-month delay, the Centers for Disease Control and Prevention (CDC) vaccine advisory committee, after meetings this week, made recommendations for three vaccines. After discussions on several vaccines yesterday and today, the Advisory Committee for Immunization Practices (ACIP) today voted on recommendations for GSK’s pentavalent (five-strain) meningococcal vaccine, respiratory syncytial vaccine (RSV) use in people ages 50 to 59
